Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Non-Hodgkin’s lymphoma B-cell

Jazirehi AR, Vega MI, Chatterjee D et al. Inhibition of the Raf-MEKl/2-ERKl/2 signaling pathway, Bel-xL down-regulation, and ehemosensitization of non-Hodgkin s lymphoma B-cells by Rituximab. Cancer Res 2004 64 7117-7126. [Pg.226]

Jazirehi, A.R., Huerta-Yepez, S., Cheng, G., and Bonavida, B. (2005). Rituximab (chimeric anti-CD20 monoclonal antibody) inhibits the constitutive nuclear factor- kappa )B signaling pathway in non-Hodgkin s lymphoma B-cell lines role in sensitization to chemotherapeutic drug-induced apoptosis. Cancer Res. 65, 264-276. [Pg.475]

Vishwanatha, J.K., Salazar, E., and V.K. Gopalakrishnan, 2004, Absence of annexin I expression in B-cell non-Hodgkin s lymphomas and cell lines. BMC Cancer. 8 4 8. [Pg.27]

Amphotericin B (AmBisome) non-Hodgkin s lymphoma renal cell carcinoma Kaposi s sarcoma Fungal infections 34... [Pg.320]

LL, a 47-year-old man, was diagnosed with high-risk diffuse large cell B-cell non-Hodgkin s lymphoma (NHL) 12 months ago. LL had a complete response to his initial treatment of six cycles of RCHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone). LL is participating in a clinical trial and is randomized to receive a myeloablative autologous HCT TBI days 8 to 5, etoposide day 4, rest day 3, cyclophosphamide day 2, rest day 1, with infusion of autologous PBPC on day 0. [Pg.1452]

Indications Treatment of patients with relapsed or refractory low-grade or follicular, B-cell non-Hodgkin s lymphoma (NHL)... [Pg.302]

B. Indications and use Rituxan is the first FDA-approved monoclonal antibody for the treatment of cancer. Several clinical trials have demonstrated efficacy of this chimeric antibody against NHL. Rituxan is indicated for the treatment of patients with relapsed or refractory low-grade or follicular B-cell non-Hodgkin s lymphoma (indolent lymphoma). [Pg.302]

Indications Treatment of patients with B-cell non-Hodgkin s lymphoma... [Pg.309]

Alas S, Emmanouilides C, Bonavida B. Inhibition of interleukin-10 by rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin s lymphoma to apoptosis. Clin Cancer Res 2001 7 709-723. [Pg.227]

Gluck WL, Hurst D, Yuen A et al. Phase I studies of interleukin (IL)-2 and rituximab in B-cell non-hodgkin s lymphoma IL-2 mediated natural killer cell expansion correlations with clinical response. Clin Cancer Res 2004 10 2253-2264. [Pg.228]

Davies AJ, Rohatiner AZ, Howell S, Britton KE, et al. 2004. Tositumomab and Iodine 1131 tositu-momab for recurrent indolent and transformed B cell non-Hodgkin s lymphoma. J Clin Oncol. 22 1469-1479. [Pg.123]

Jazirehi AR, Bonavida B. 2004. Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin s lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis. Mol Cancer Ther 3 71-84. [Pg.324]

IL-14. IL-14 can be produced by aggressive intermediate (diffuse large cell) lymphomas of B cell-type non-Hodgkin s lymphoma (NHL-B) in patients with lymphomatous effusions. The autocrine or paracrine production of IL-14 may play a significant role in the rapid proliferation of aggressive NHL-B (F4). [Pg.4]

CIO. Chadburn, A., and Knowles, D. M., Paraffin-resistant antigens detectable by antibodies L26 and polyclonal CD3 predict the B- or T-cell lineage of 95% of diffuse aggressive non-Hodgkin s lymphomas. Am. J. Clin. Pathol. 102, 284-291 (1994). [Pg.333]

G4. Gloghini, A., De Paoli, P., Gaidano, G., Franceschi, S., and Carbone, A., High frequency of CD45RO expression in AIDS-related B-cell non-Hodgkin s lymphomas. Am. J. Clin. Pathol. 104, 680-688 (1995). [Pg.337]


See other pages where Non-Hodgkin’s lymphoma B-cell is mentioned: [Pg.136]    [Pg.136]    [Pg.421]    [Pg.1137]    [Pg.189]    [Pg.136]    [Pg.136]    [Pg.421]    [Pg.1137]    [Pg.189]    [Pg.2439]    [Pg.164]    [Pg.466]    [Pg.604]    [Pg.271]    [Pg.135]    [Pg.151]    [Pg.126]    [Pg.132]    [Pg.461]    [Pg.461]    [Pg.325]    [Pg.140]    [Pg.303]    [Pg.312]    [Pg.205]    [Pg.97]    [Pg.116]    [Pg.48]    [Pg.1348]    [Pg.318]    [Pg.334]    [Pg.339]    [Pg.342]   
See also in sourсe #XX -- [ Pg.1373 , Pg.1374 , Pg.1374 , Pg.1375 ]




SEARCH



B cells

B lymphoma

B-cell lymphomas

Hodgkin

Hodgkin’s lymphoma

Lymphoma

Lymphoma Hodgkin

Lymphoma cells

Lymphoma non-Hodgkin

Lymphomas Hodgkin lymphoma

Lymphomas lymphoma

Non-Hodgkin’s lymphoma

S cells

© 2024 chempedia.info